Virtual Case Library: Metastatic Triple-Negative Breast Cancer
Breast Cancer Update
00:00
Exploring the Synergy of Immune Checkpoint Inhibitors with Antibody-Drug Conjugates in Cancer Treatment
This chapter delves into the synergy and efficacy of combining immune checkpoint inhibitors and antibody-drug conjugates in cancer treatment, focusing on ongoing trials in triple-negative breast cancer patients. The discussion also compares the advantages of ADCs over traditional chemotherapy in pre-treated patients.
Play episode from 59:56
Transcript
